Trending Now
Midatech Pharma PLC (NASDAQ: MTP) Receives Fast Track Designation for MTX110...
Midatech Pharma PLC (NASDAQ: MTP) has announced that after filing an application with the US FDA for its MTX110 development program for recurrent glioblastoma...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Bitcoin Stocks Primed as Inflation Concerns Build (BKKT, ISWH, RIOT, MARA,...
The concept of a “safe haven” is critical for investors to understand when they consider cross asset capital flows. One key philosophical...
MAKE IT MODERN
LATEST REVIEWS
Allakos Inc. (NASDAQ: ALLK) Releases Results of The ENIGMA And KRYPTOS...
Allakos Inc. (NASDAQ: ALLK) has released results from ENIGMA 2 study, which is a third phase, 24-week, double-blind, controlled lirentelimab study in patients with...
MAKE IT MODERN
PERFORMANCE TRAINING
US FDA Accepts Ocugen Inc.’s (NASDAQ: OCGN) Investigational New Drug Application TO commence Phase...
Ocugen Inc. (NASDAQ: OCGN) has announced that the FDA has cleared its Investigational New Drug application to commence the first-in-human study of OCU400, a...
Penny Stocks are back in focus (BBD,DIDIY,APE,TLRY,FCEL)
In today's market, several penny stocks showed remarkable activity and experienced significant price changes. Here's a list of the top active penny...
Novavax Inc. (NASDAQ: NVAX) Announces That CoV2373 Achieved Efficacy Endpoint in Paediatric Population in...
Novavax Inc. (NASDAQ: NVAX) had announced that its recombinant nanoparticle protein-based SARS-CoV-2 vaccine, CoV2373, attained primary efficacy endpoint in the paediatric expansion of the...
It’s Time for Healthcare Stocks 2.0 (TDOC, RXMD, GDRX)
The shift in the healthcare space over the past six months is perhaps the most striking of all for market participants, from a thematic...
Humanigen Inc. (NASDAQ:HGEN) Announce Encouraging Phase 3 Lenzilumab Study Results in Hospitalized COVID-19...
Humanigen Inc. (NASDAQ:HGEN) has announced encouraging topline results from its third phase clinical study evaluating the safety and efficacy of lenzilumab in treating hospitalized...
MAKE IT MODERN
